Suppr超能文献

阿莫西林和甲硝唑在初始牙周治疗后的额外临床及微生物学效应。

Additional clinical and microbiological effects of amoxicillin and metronidazole after initial periodontal therapy.

作者信息

Winkel E G, van Winkelhoff A J, van der Velden U

机构信息

Clinic of Periodontology Amsterdam, Department of Periodontology, Academic Centre for Dentistry Amsterdam, The Netherlands.

出版信息

J Clin Periodontol. 1998 Nov;25(11 Pt 1):857-64. doi: 10.1111/j.1600-051x.1998.tb02382.x.

Abstract

The aims of this study were to evaluate the clinical and microbiological effects of initial periodontal therapy (IT) and to determine the additional effects of systemic amoxicillin (Flemoxin Solutab) 375 mg TID plus metronidazole 250 mg TID therapy, in patients with adult Actinobacillus actinomycetemcomitans (Aa)-associated periodontitis in conjunction with either Porphyromonas gingivalis (Pg), Bacteroides forsythus (Bf) and/or Prevotella intermedia (Pi). In addition the adverse effects of the antimicrobial therapy were also documented. A total of 22 patients were enrolled. The deepest, bleeding pocket in each quadrant was selected and at these 4 experimental sites clinical measurements and microbiological testing was carried out at baseline, after (IT), i.e., 21 weeks after baseline, and after antimicrobial therapy (AM), i.e., 35 weeks after baseline. At baseline, the mean plaque index (PI) amounted 0.5, 0.1 after IT and 0.3 after systemic AM. The mean bleeding index decreased from 1.6 to 1.2 after IT and a further decrease to 0.7 after AM was noted. Suppuration was completely eliminated after AM. The mean change of probing pocket depth (PPD) after IT amounted 1.4 mm and was further reduced with an additional mean change of 1.1 mm after medication. Clinical attachment gain was 1.1 mm after IT and an additional 0.9 mm was observed after AM. One of the 22 Aa positive patients and 4 of 17 Pg positive patients became negative for these species after IT. The number of patients with detectable Pi decreased from 16 to 10 after IT. After AM, in comparison to baseline, suppression below detection level for Aa was achieved in 19 out of 22, for Pg in 9 out of 17, for Bf in 13 out of 14, and for Pi in 11 out of 16 patients. By contrast, higher frequencies of Peptostreptococcus micros and Fusobacterium nucleatum were found after AM. On the basis of the microbiological results the study group was separated into 2 subgroups: group A consisted of subjects who had no detectable levels of Aa, Pg, Bf and <5% of Pi after AM. Group B consisted of those who still showed presence of one of these 3 species and/or > or =5% levels of Pi. After AM, group B had significantly higher PI, BI, PPD and CAL scores then group A. It is concluded that group A showed low plaque scores and no detectable periodontal pathogens. This microbiological condition has been associated with a long-term stable periodontium.

摘要

本研究旨在评估初始牙周治疗(IT)的临床和微生物学效果,并确定全身性阿莫西林(Flemoxin Solutab)375毫克每日三次加甲硝唑250毫克每日三次联合治疗,对患有伴放线放线杆菌(Aa)相关性牙周炎且合并牙龈卟啉单胞菌(Pg)、福赛坦氏菌(Bf)和/或中间普氏菌(Pi)的成年患者的额外效果。此外,还记录了抗菌治疗的不良反应。共纳入22例患者。在每个象限中选择最深的出血袋,并在这4个实验部位于基线时、(IT)后,即基线后21周,以及抗菌治疗(AM)后,即基线后35周进行临床测量和微生物检测。基线时,平均菌斑指数(PI)为0.5,IT后为0.1,全身性AM后为0.3。平均出血指数在IT后从1.6降至1.2,AM后进一步降至0.7。AM后化脓完全消除。IT后探诊袋深度(PPD)的平均变化为1.4毫米,用药后平均再减少1.1毫米。IT后临床附着获得为1.1毫米,AM后又观察到0.9毫米的增加。22例Aa阳性患者中有1例,17例Pg阳性患者中有4例在IT后这些菌种变为阴性。可检测到Pi的患者数量在IT后从16例降至10例。AM后,与基线相比,22例患者中有19例Aa、1..7例患者中有9例Pg、14例患者中有13例Bf以及16例患者中有11例Pi被抑制至检测水平以下。相比之下,AM后微小消化链球菌和具核梭杆菌的检出频率更高。根据微生物学结果,研究组被分为2个亚组:A组由AM后未检测到Aa、Pg、Bf且Pi水平<5%的受试者组成。B组由仍显示这3种菌种之一存在和/或Pi水平>或=5%的患者组成。AM后,B组的PI、BI、PPD和CAL评分显著高于A组。得出的结论是,A组菌斑评分低且未检测到牙周病原体。这种微生物学状况与长期稳定的牙周组织相关。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验